Fol. Biol. 2011, 57, 191-199
https://doi.org/10.14712/fb2011057050191
Study of the Effect of Neoadjuvant Chemotherapy on the Status of Her2/neu
References
1. 2008) The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and Her2/neu status in breast carcinoma. Breast J. 14, 141-146.
< , A. L., Eltoum, I., Krontiras, H., Wang, W., Chhieng, D. C. (https://doi.org/10.1111/j.1524-4741.2007.00544.x>
2. 1998) Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J. Clin. Oncol. 16, 1340-1349.
< , I. L., Bull, S. B., Blackstein, M. E., Sutherland, D., Mak, C., Sidlofsky, S., Pritzker, K. P., Hartwick, R. W., Hanna, W., Lickley, L., Wilkinson, R., Qizilbash, A., Ambus, U., Lipa, M., Weizel, H., Katz, A., Baida, M., Mariz, S., Stoik, G., Dacamara, P., Strongitham, D., Geddie, W., McCready, D. (https://doi.org/10.1200/JCO.1998.16.4.1340>
3. 1999) Real-time reverse transcription-PCR assay for future management of ERBB2based clinical applications. Clin. Chem. 45, 1148-1156.
< , I., Onody, P., Laurendeau, I., Martine, O., Vidaud, D., Lidereau, R., Vidaud, M. (https://doi.org/10.1093/clinchem/45.8.1148>
4. 2010) Accurately assessing Her2/neu status in needle core biopsy of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed. Am. J. Surg. Pathol. 34, 575-581.
< , T., Liu, Y. F., Monni, S., Rosen, P. P., Shin, S. J. (https://doi.org/10.1097/PAS.0b013e3181d65639>
5. 2010) Progression and treatment of HER2-positive breast cancer. Cancer Chemother. Pharmacol. 65, 611-623.
< , A., Hocevar, B. A., Brown, T. L. (https://doi.org/10.1007/s00280-009-1208-1>
6. 2005) Predictive markers in breast and other cancers: a review. Clin. Chem. 51, 494-503.
< , M. J. (https://doi.org/10.1373/clinchem.2004.046227>
7. 1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352, 930-942.
(
8. 2002) Her2/neu amplification in breast cancer: stratification by tumor type and grade. Am. J. Clin. Pathol. 117, 916-921.
< , E. R., Tubb, R. R., Myles, J. L., Procop, G. W. (https://doi.org/10.1309/4NTU-N6K4-F8JF-EWRX>
9. 2007) Changes in protein expression in breast cancer after anthracycline-based chemotherapy. Korean J. Pathol. 41, 165-170.
, H., Lee, J., Park, I. A. (
10. 2001) Quantification of HER2/neu gene amplification by competitive PCR using fluorescent melting curve analysis. Clin. Chem. 47, 844-851.
< , E., Millson, A., Lowery, M. C., Woods, R., Wittwer, C. T. (https://doi.org/10.1093/clinchem/47.5.844>
11. 1994) Unbalanced t(1;16) as the sole karyotypic abnormality in a breast carcinoma and its lymph node metastasis. Cancer Genet. Cytogenet. 75, 158-159.
< , N., Bardi, G., Jin, Y., Dietrich, C., Johansson, B., Andersen, J., Mandahl, N., Mitelman, F., Heim, S. (https://doi.org/10.1016/0165-4608(94)90172-4>
12. 1995a) Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12, 173-185.
< , N., Jin, Y., Gorunova, L., Petersson, C., Bardi, G., Idvall, I., Johansson, B., Ingvar, C., Mandahl, N., Mitelman, F. (https://doi.org/10.1002/gcc.2870120304>
13. 1995b) Chromosome abnormalities in bilateral breast carcinomas. Cancer 76, 250-258.
< , N., Teixeira, M. R., Gerdes, A. M., Limon, J., Bardi, G., Anderson, J. A., Idvall, I., Mandahl, N., Mitelman, F., Heim, S. (https://doi.org/10.1002/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W>
14. 1998) Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 22, 122-129.
< , N., Teixeira, M. R., Adeyinka, A., Rizou, H., Bardi, G., Mertens, F., Andersen, J. A., Bondeson, L., Sfikas, K., Qvist, H., Apostolikas, N., Mitelman, F., Heim, S. (https://doi.org/10.1002/(SICI)1098-2264(199806)22:2<122::AID-GCC6>3.0.CO;2-Z>
15. 1991) Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51, 556-567.
, M. C., Dietrich, K. D., Danyluk, J., Paterson, A. H., Lees, A. W., Jamil, N., Hanson, J., Jenkins, H., Krause, B. E., McBlain, W. A. (
16. 1997) HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. Clin. Oncol. 15, 2894-2904.
< , M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G.., Robinson, R. A., Harris, C., El-Naggar, A., Slamon, D. J., Phillips, R. N., Ross, J. S., Wolman, S. R., Flom, K. J. (https://doi.org/10.1200/JCO.1997.15.8.2894>
17. 2005) Her2/neu expression in locally advanced breast carcinomas: preand post-neoadjuvant chemotherapy. Breast Cancer 12, 294-298.
< , R. M., Sung, J. C., Zhang, C., Pasqueriello, T., Eklund, M., Steinhoff, M. M. (https://doi.org/10.2325/jbcs.12.294>
18. 2010) Nucleic acid sequence-based amplification in formalin-fixed and paraffin-embedded breastcancer tissues. J. Clin. Pathol. 63, 1071-1076.
< , U., Mader, A., Brandstetter, T., Rühe, J., Zur Hausen, A., Stickeler, E. (https://doi.org/10.1136/jcp.2010.078766>
19. 1989) C-erbB-2 amplification in node-negative human breast cancer. Cancer Res. 49, 6941-6944.
, J. S., El-Naggar, A., Ro, J. Y., Blick, M., Frye, D., Fraschini, G.., Fritsche, H., Hortobagyi, G.. (
20. 1990) Protooncogene amplification and homogeneously staining regions in human breast carcinomas. Genes Chromosomes Cancer 2, 18-26.
< , C., Gerbault-Seureau, M., Viegas-Péquignot, E., Zafrani, B., Cassingena, R., Dutrillaux, B. (https://doi.org/10.1002/gcc.2870020105>
21. 1991) Recurrent homogeneously staining regions in 8pl in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes. Cancer Genet. Cytogenet. 52, 27-35.
< , C., Gerbault-Sanreau, M., Viegas-Péquignot, E., Zafrani, B., Malfoy, B., Dutrillaux, B. (https://doi.org/10.1016/0165-4608(91)90050-5>
22. 1987) Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235, 177-182.
< , D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., McGuire, W. L. (https://doi.org/10.1126/science.3798106>
23. 1989) Studies of Her2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.
< , D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G.., Udova, J., Ullrich, A. (https://doi.org/10.1126/science.2470152>
24. 2003) Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of Her2/neu in patients with breast cancer. Breast Cancer Res. Treat. 82, 207-213.
< , S., Rudas, M., Mader, R. M., Gnant, M., Sporn, E., Dubsky, P., Roka, S., Bachleitner, T., Fitzal, F., Kandioler, D., Wenzel, C., Steger, G.. G., Mittlböck, M., Jakesz, R. (https://doi.org/10.1023/B:BREA.0000004378.15859.51>
25. Tavassoli, F. A., Devilee, P. (2004) WHO Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. IARC Press, Lyon.
26. 1994) Cytogenetic analysis of multifocal breast carcinomas: Detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br. J. Cancer 70, 922-927.
< , M. R., Pandis, N., Bardi, G., Andersen, J. A., Mandhal, N., Mitelman, F., Heim, S. (https://doi.org/10.1038/bjc.1994.421>
27. 2001) Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis. Neoplasia 3, 204-214.
< , M. R., Tsarouha, H., Kraggerud, S. M., Pandis, N., Dimitriadis, E., Andersen, J. A., Lothe, R. A., Heim, S. (https://doi.org/10.1038/sj.neo.7900152>
28. 2006) Changes of topoisomerase IIα expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. Clin. Cancer Res. 12, 1501-1506.
< , N., Lattanzio, R., Natoli, C., Cianchetti, E., Angelucci, D., Ricevuto,E., Ficorella C., Marchetti, P., Alberti, S., Piantelli, M., Iacobelli, S. (https://doi.org/10.1158/1078-0432.CCR-05-0978>
29. 2005) Molecular diagnosis of synovial sarcoma: detection of SYT-SSX1/2 fusion transcripts by RT-PCR in paraffin-embedded tissue. Med. Sci. Monit. 11, MT1-7.
, D., Svatošová, J., Dundr, P., Povýšil, C. (
30. 2005) Gene-expression profiling and the future of adjuvant therapy. Oncologist 10 (Suppl 2), 30-34.
< , M. (https://doi.org/10.1634/theoncologist.10-90002-30>
31. 2005) Stability of the Her2 gene after primary chemotherapy in advanced breast cancer. Virchows Arch. 446, 136-141.
< , Z., Caduff, R., Pestalozzi, B. (https://doi.org/10.1007/s00428-004-1164-4>